Description: Presented at May 1996 Spring Meeting. This session analyzes the factors that influence the mortality differences between countries and between population and insured-lives mortality.

Description: Whether focused on mortality, longevity, health or disability risks, biometric uncertainty is the foundation of our work. With a long history of processes and methods for analyzing biometric considerations, we run the risk of becoming stagnant in our thinking about the subject. The presenters will explore how companies can stay ahead of the curve in an environment of ever-changing medical and biometric influencers. They'll dig into cause of death trends, the obesity epidemic, genetic testing, wearables, other wellness tools and more. The presenters will also address the impact of changing risk assessment methods through predictive underwriting. This session is for anyone interested in staying at the forefront of biometric risk.

Description: This session discusses two recent SOA research initiatives called FARM I and FARM II. From Record of Society of Actuaries, Vol. 30, No. 3.

Description: Discusses the natural history of AIDS and some of the impact on underwriting, the methods for projecting the epidemic from both a population and insurance standpoint, the potential of the AIDS epidemic in terms of reinsurance and solvency reserves. From the 1988 Record of Society of Actuaries, Vol. 14, No. 2.

Description: This panel discussion session presents social indicators using a variety of statistical approaches and relates them to societal changes. The concept of using mortality data as a social indicator is also discussed.

Description: Medical and underwriting experts discuss medical developments and underwriting practices that could improve mortality rates and risk classification, respectively, in the future. From the 1988 Record of Society of Actuaries, Vol. 14, No. 3.

Description: In the first part of this series, the presenters will provide the results of a recent SOA multi-country survey on mortality improvement practices of life insurance companies. In the second part of this session, they will discuss the issues and solutions related to the development of the most recent RPEC mortality improvement assumptions.